Substituted imidazopyridazines

US9512126B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Marcus Koppitz · Berlin, DE
• Ulrich Klar · Berlin, DE
• Antje Margret Wengner · Berlin, DE
• Roland Neuhaus · Berlin, DE
• Gerhard Siemeister · Berlin, DE

Key dates

• Filing date: Mar 11, 2013
• Grant date: Dec 6, 2016
• Expiry date: Mar 11, 2033

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to substituted imidazopyridazine compounds of general formula I in which R3, R5 and A are as defined in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.